Treatment of trigeminal neuralgia by posterior fossa microvascular decompression

K Cutbush1, R L Atkinson

  • 1Department of Neurosurgery, Princess Alexandra Hospital, Brisbane, Queensland, Australia.

Insights

Microvascular decompression effectively treats trigeminal neuralgia, with a 17.6% failure rate and manageable complications. Modifications to the surgical approach reduced hearing loss significantly.

Area of Science:

  • Neurosurgery
  • Neurology

Background:

  • Trigeminal neuralgia is a debilitating neuropathic pain condition.
  • Microvascular decompression is a primary surgical treatment for trigeminal neuralgia.
  • Understanding surgical outcomes and complications is crucial for patient management.

Purpose of the Study:

  • To evaluate the efficacy and safety of microvascular decompression for intractable trigeminal neuralgia.
  • To identify factors influencing treatment success and recurrence.
  • To assess the impact of surgical modifications on outcomes.

Main Methods:

  • Retrospective review of 109 microvascular decompression cases for trigeminal neuralgia.
  • Single surgeon performed all operations; single author reviewed cases.
  • Analysis of failure rates, recurrences, complications, and surgical approach modifications.

Main Results:

  • The overall failure rate was 17.6%, with an additional 6.5% experiencing brief, non-requiring treatment recurrences.
  • Two-thirds of significant recurrences occurred within 12 months post-operation.
  • A modified surgical approach reduced hearing loss from 12.5% to 3.7%; aberrant superior cerebellar artery compression was common (over 70%).

Conclusions:

  • Microvascular decompression offers a viable treatment for trigeminal neuralgia with a notable success rate.
  • Surgical technique modifications can significantly improve patient outcomes, particularly regarding hearing preservation.
  • Early recurrence is common, highlighting the need for long-term patient monitoring.

Related Concept Videos